期刊文献+

盐酸西布曲明衍生光度法分析研究 被引量:2

Study and analysis on derivative spectrophotometry of sibutramine hydrochloride
下载PDF
导出
摘要 目的:通过衍生反应,建立了用分光光度法测定盐酸西布曲明的新方法。方法:并对影响吸收强度的衍生体系、反应条件、产物稳定性等进行了研究。实验确定丙二酸和乙酸酐混合试剂与盐酸西布曲明在90℃的水浴中加热20 min,溶液呈深棕色,所得产物在370和328 nm 波长处有吸收峰,其中370 nm 处吸收最大。结果:在370 nm 波长处测得吸光度与盐酸西布曲明的浓度在0.15~12.5 μg·mL^(-1)范围内呈线性关系,遵守比尔定律,表观摩尔吸收系数为2.098×10~5 L·mol^(-1)·cm^(-1),检出限49 ng·mL^(-1),回收率为96.1%~102.6%。结论:本法用于曲美胶囊中盐酸西布曲明的测定,结果满意。 Objective:Based on derivative reaction, a sensitive derivative spectrophotometry method was developed for determination of sibutramine hydrochloride. Methods: The derivative system, reaction conditions, stability of the products were studied in detailed. The MAA system and sibutramine hydrochloride was simple to reaction was completed for 20 min at 90 ℃, got the deep brown liquid, the product had highly absorpti prepare and on at 370 nm and 328 nm, respectively, the maximum absorption wavelength of reaction product was located at 370 nm. Resuits :The concentration of sibutramine hydrochloride in the range of 0. 15 -12. 5 μg · mL^-1 obeyed Beer' law, the apparent molar absorptivity was 2. 098 ×105 L · mol^- 1 . cm^-1 the detection limit was 49 ng · mL^-1the recovery was 96. 1% - 102. 6%. Conclusions: The method is applied to the determination of sibutramine hydrochloride in Qumei capsules, with satisfactory results.
出处 《药物分析杂志》 CAS CSCD 北大核心 2006年第11期1656-1658,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 盐酸西布曲明 衍生 分光光度法 丙二酸 乙酸酐 sibutramine hydrochloride derivative spectrophotometry malonic acid acetic anhydride
  • 相关文献

参考文献9

二级参考文献32

  • 1[1]James WPT, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomized trial[J].Lancet, 2000;356:2119-2125.
  • 2[2]Wirth A, Krauoo J. Long-term weight loss with sibutramine :A randomized controlled trial[J]. JAMA, 2001; 286:1331-1339.
  • 3[3]Kissebach AH ,Vydelingum N, Murray RW, et al. Relation of body fat distribution to metabolic complications of obesity [J].J Clin Endocrinol Metab, 1982; 54:254-260.
  • 4[4]Lapidus L ,Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow up of participants in the population study of women in Gothenburg ,Sweden[J]. Br Med J, 1984;289:1261-1263.
  • 5[5]Hubert HB, Feinlieb M, Mcnamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study[J].Circulation, 1983;67:5-14
  • 6[6]Larsson B, Svarsudd K, Welin L, et al. Abdominal adipose tissue distribution ,obesity and risk of cardiovascular disease and death:13-year follow up participants in the study of men born in 1913[J].Br Med J, 1984;288:1401-1404.
  • 7[7]Goldstein DJ. Beneficial health effects of modest weight loss[J].Int J Obes Relat Met Dis, 1992; 16:397-415.
  • 8[8]Hansen DL ,Toubro S, Stock MJ, et al. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction[J]. Int J Obesity, 1999;23:1016-1024.
  • 9Yang JW. ( Sepracor Inc. ) Methods and composition for treating depression and other disorders using optically pure ( + ) sibutramine.PCT Int. Appl. WO 9400047 ( Cl. A51K31/45) ,06 Jan 1994,US Appl. 903034,23 Jun 1992 ;40pp.
  • 10Yang JW. ( Sepracor Inc. ) Pharnlaceutical compositions for treating depression and other cerebral disorders containing optically pure( - )sibutramine. PCT Int. Appl. WO 9400114( Cl. A61 K31/135 ) ,06 Jan1994, US Appl. 903040,23 Jun 1992 ;40pp.

共引文献48

同被引文献15

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部